Emergent BioSolutions Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/E Ratio10.6515.53
Forward P/E12.5751.157.189.53
P/S Ratio0.500.120.531.323.01
P/B Ratio1.070.190.421.453.28
Price/Tangible Book1.511.342.999.18
Price/FCF14.4724.3412.02
Price/OCF8.827.308.85
PEG Ratio11.760.210.68
Enterprise Value Ratios
EV/Revenue1.000.871.261.593.33
EV/EBITDA19.5590.085.608.63
EV/EBIT7.3210.53
EV/FCF29.1629.3913.30
Profitability & Returns
Return on Equity (ROE)-0.34%-0.75%-0.14%0.14%0.24%
Return on Assets (ROA)-0.02%-0.04%-0.02%0.08%0.12%
Return on Invested Capital (ROIC)-0.04%-0.09%-0.05%0.15%0.21%
Return on Capital Employed (ROCE)-0.04%-0.14%-0.06%0.15%0.20%
Leverage & Solvency Ratios
Debt/Equity1.401.351.030.540.64
Debt/EBITDA12.6690.851.721.50
Debt/FCF18.899.132.34
Liquidity Ratios
Current Ratio3.691.040.983.403.11
Quick Ratio1.560.470.662.292.22
Efficiency Ratios
Asset Turnover0.650.420.360.610.60
Inventory Turnover2.292.342.383.012.70
Yield & Distribution Ratios
Earnings Yield-0.37%-6.11%-0.36%0.09%0.06%
FCF Yield0.07%-2.07%-0.25%0.04%0.08%
Buyback Yield-0.04%-0.02%0.07%-0.01%-0.03%